[1]
Dr Gaurav Thukral, Dr Vipulkumar Thummar, Dr Priya Mehta, Dr. Vijay Janagama and Keyur Khambhati 2023. Drug Utilization Pattern of World’s First T-DM1 Biosimilar (UJVIRATM) For Her2+ Breast Cancer in First Year of Its Availability – An Indian Context. International Journal of Medical Science and Clinical Invention. 10, 02 (Feb. 2023), 6561–6568. DOI:https://doi.org/10.18535/ijmsci/v10i02.04.